Re: RE: phenergan

[ccavrn]

Well, you could try having the pharmacist pull up the pH and osmolarity of the drug, and bring out the INS standards to compare it to....that is what works for the lawyers in the cases I have testified in.

Chris Cavanaugh, CRNI

----- Original Message -----
From: Heather Nichols <[EMAIL PROTECTED]>
Date: Wednesday, March 1, 2006 5:31 pm
Subject: RE: phenergan
To: [EMAIL PROTECTED], [EMAIL PROTECTED], [EMAIL PROTECTED], [EMAIL PROTECTED], [EMAIL PROTECTED]

> Ask the pharmacist if he/she can explain to you why phenergan
> burns like liquid fire when it is injected into the "good vein",
> but not when it is given centrally.
>
> Heather Nichols RN BSN CRNI
> Infusion Services
> University of Louisville Trauma Institute
> 530 S. Jackson St.
> Lou. Ky. 40202
> (502)562-3530
>
> >>> "Feckers, Charlotte" <[EMAIL PROTECTED]> 03/01/06 3:16 PM >>>
>
> To the group: I read this e-mail this am and sure enough we had a
> Doc order phenergan 12.5 Iv I spoke up and said it had just been
> on the link how bad it was. He and the pharmacist both told me it
> was fine to give as long as you make sure you have a good vein....
> Not a central line but a good vein. The pharmacist told me if it
> was as bad as I was saying we would have had it pulled from the
> shelves. Anyone out there this afternoon with some good come
> backs I don't have a lot of time this afternoon to research articles.
> Thanks in advance Charlotte RNCRNI
>
> -----Original Message-----
> From: [EMAIL PROTECTED] [mailto:owner-
> [EMAIL PROTECTED] On Behalf Of Lynn Hadaway
> Sent: Wednesday, March 01, 2006 10:54 AM
> To: Kilbourne, Susan; [EMAIL PROTECTED]; [EMAIL PROTECTED]
> Subject: Re: phenergan
>
>
> While there are numerous lawsuits involving promethazine injuries,
> there is not much that has ever been published. The following are
> the only ones that I know of:
> Extravasation of I.V. promethazine M. Malesker, P. Malone, C.
> Cingle, R. Cochran American journal of health-System pharmacy
> unusual drug experiences, FDA, promethazine injection, intra-
> arterial injection, extravasation, dominal hysterectomy 05-14-
> 01 Vol. 56, September 1, 1999 1742-1743 2049
> Case Report
>
>
> Accidental intra-arterial injection of promethazine HCI during
> general anesthesia: report of a case H. Mostafavi, M. Samimi
> Anesthesiology intra-arterial injection, promethazine
> hydrochloride (Phenergan), anesthesia 10-30-02 Vol. 35,
> No. 6, December 1971 645-646 2836 Case Report
>
>
> Promethazine adverse events after implementation of a medication
> shortage interchange. H. Sheth, M. Verrico, S. Skedar, A. Towers
> Ann Pharmacother promethazine, adverse events, 11-11-
> 5 Volume 39, Number 2, February 2005 255-261 5265 Abstract
>
>
> Adverse reactions related to phenergan C. Blankenship
> Gastroenterology Nursing Phenergan, arterial misplacement,
> PICC, pediatrics, seizure activity 11-04-04 Volume 24,
> Number 3 149-150 3985 Review
>
>
> At 5:23 PM -0800 2/28/06, Kilbourne, Susan wrote:
> We are finally having a team meeting at our hospital to discuss
> the use of IV phenergan through peripheral lines after having two
> problems in the past year. The problem is convincing the MDs. Can
> anyone point me to some specific literature to support of dangers
> of infiltrated phenergan?
> Thanks in advance,
> Sue Kilbourne CRNI, OCN
>
>
> NOTE: The information contained in this message may be privileged
> and confidential and protected from disclosure. If the reader of
> this message is not the intended recipient, or an employee or
> agent responsible for delivering this message to the intended
> recipient, you are hereby notified that any dissemination,
> distribution or copying of this communication is strictly
> prohibited. If you have received this communication in error,
> please notify us immediately by replying to the message and
> deleting it from your computer.
> E-mail has the potential to have been altered or corrupted due to
> transmission or conversion. It may not be appropriate to rely upon
> this E-mail in the same manner as hardcopy materials bearing the
> author's original signature or seal. Thank you. Asante® Health System
>
>
>
> -- Lynn Hadaway, M.Ed., RNC, CRNI
> Lynn Hadaway Associates, Inc.
> 126 Main Street, PO Box 10
> Milner, GA 30257
> http://www.hadawayassociates.com
> office 770-358-7861
> Privileged/Confidential information may be contained in this
> message. The information contained in this message is intended
> only for the use of the recipient(s) named above and their co-
> workers who are working on the same matter. The recipient of this
> information is prohibited from disclosing the information to any
> other party unless this disclosure has been authorized in advance.
>
> If you are not intended recipient of this message or any agent
> responsible for delivery of the message to the intended recipient,
> you are hereby notified that any disclosure, copying, distribution
> or action taken in reliance on the contents of this message is
> strictly prohibited. You should immediately destroy this message
> and kindly notify the sender by reply E-Mail. Please advise
> immediately if you or your employer does not consent to Internet E-
> Mail for messages of this kind. Opinions, conclusions and other
> information in this message that do not relate to the official
> business of the firm shall be understood as neither given nor
> endorsed by it.
>
>
> -----------------------------------------------------
> Confidentiality Disclaimer
>
> This message, including any attachments, is confidential and intended
> only for the named recipient(s) and may contain information that is
> privileged or exempt from disclosure under applicable law, including
> PHI (Protected Health Information) covered under the Health Insurance
> Portability and Accountability Act (HIPAA) of 1996. If you are not
> the intended recipient(s), you are notified that the
> dissemination,
> distribution, or copying of this message is strictly prohibited.
> If you receive this message in error, or are not the named
> recipient(s),
> please notify the sender or contact the University of Louisville
> Health
> Care I.S. helpdesk at 502.562.3637 to report an inadvertently received
> message.
>
> -----------------------------------------------------